Please login to the form below

Not currently logged in
Email:
Password:

Watson

This page shows the latest Watson news and features for those working in and with pharma, biotech and healthcare.

Bayer looks to leverage AI across the pharma value chain

Bayer looks to leverage AI across the pharma value chain

The company is, he said, “all over this”, having already collaborated with the likes of Verily, the life sciences unit at Google parent company Alphabet, and IBM’s Watson and Deep ... I can see artificial intelligence in diagnosis. IBM Watson has a

Latest news

More from news
Approximately 17 fully matching, plus 141 partially matching documents found.

Latest Intelligence

  • European venture funding for the life science sector European venture funding for the life science sector

    And within the specific field of AI/ML there is certainly a degree of hype that has not been matched by evidence to date - IBM’s Watson for Oncology was recently

  • So, you think you can multitask? So, you think you can multitask?

    IBM has been working with healthcare companies in the US with the aim of using its AI technology, Watson, to improve diagnosis and reduce costs at the same time. ... Watson has absorbed more than 600, 000 pieces of medical evidence and more than two

  • A healthcare landscape going through seismic change A healthcare landscape going through seismic change

    We connect with IBM Watson and Google on a global level and we now have ten of these hubs.

  • Digital disruption Digital disruption

    It’s a road whose signposts point strongly towards data, with the tech firms attending a two-day EMA workshop in November 2016 - among them IBM Watson Health and Google - having ... R&D, this time within psychiatric and neurological treatments, was in

  • Here’s to all the bright sparks Here’s to all the bright sparks

    In 1953, James Watson and Francis Crick published a paper detailing what is now regarded as the first correct double-helix model of DNA structure in the journal Nature. ... In other words, ‘The Big Idea’. Just as Fleming had his eureka moment staring

More from intelligence
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • Artificial Intelligence: the new healthcare algorithm

    For example, an oncologist can use WATSON to assist in diagnosing and treating cancer patients. ... This contextual analysis allows WATSON to address complex problems, helping the doctor make more informed and accurate decisions.

  • 2018: A pivotal year for outsourcing

    2018: A pivotal year for outsourcing. Managing Director of Ashfield Commercial and Clinical UK, Colin Watson, sat down with Pf Magazine to talk about meeting changing industry demands, new innovations for

  • Ashfield achieves another double win at the PF Awards 2017

    Thank you Ashfield, what a great team!”. Commenting on the win, Colin Watson, Managing Director of Ashfield Commercial and Clinical UK, said: “ We are delighted our employees have been recognised by

  • Pragmatic Digital Health

    The planned integration of Merge Healthcare’ s capabilities with IBM’ s Watson platform means we are now conceivably a step closer at seeing a computer determine a diagnosis from a scan ... data collection and analytic capabilities offered by IBM’

  • Who will be the new disrupter of HCP media

    IBM Watson, the cognitive computer system from IBM, is already helping healthcare professionals to learn, diagnose and manage patient care better.

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics